Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Innoviva Inc (NASDAQ:INVA)

13.43
Delayed Data
As of 3:59pm ET
 +0.19 / +1.44%
Today’s Change
10.29
Today|||52-Week Range
14.87
+25.51%
Year-to-Date
No recent news for Innoviva Inc.

Today’s Trading

Previous close13.24
Today’s open13.26
Day’s range13.26 - 13.45
Volume4,367
Average volume (3 months)931,111
Market cap$1.4B
Data as of 3:59pm ET, 12/12/2017

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)+107.08%
Earnings growth (next 5 years)+56.67%
Revenue growth (last year)+117.48%
P/E ratio15.1
Price/Sales8.95
Price/Book--

Competitors

 Today’s
change
Today’s
% change
PCRXPacira Pharmaceutica...+1.10+2.49%
EBSEmergent BioSolution...+1.36+3.08%
LXRXLexicon Pharmaceutic...0.000.00%
IPXLImpax Laboratories I...+1.15+6.91%
Data as of 4:02pm ET, 12/12/2017

Financials

Next reporting dateFebruary 8, 2018
EPS forecast (this quarter)$0.42
Annual revenue (last year)$147.4M
Annual profit (last year)$59.5M
Net profit margin40.39%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Michael W. Aguiar
Chief Financial Officer &
Senior Vice President
Eric d'Esparbes
Corporate headquarters
Brisbane, California

Forecasts